Healthy Skepticism Library item: 16936

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Morris L, Taitsman JK
The Agenda for Continuing Medical Education— Limiting Industry’s Influence
NEJM 2009 Dec 17; 361:(25):2478-2482
http://content.nejm.org/cgi/content/short/361/25/2478?query=TOC

Abstract:

Most physicians must complete accredited continuing medical education (CME) programs to maintain their medical licenses, hospital privileges, and specialty board certifications. Data from the Accreditation Council for Continuing Medical Education (ACCME) show that CME is a $2 billion per year business in the United States that earns less than half its revenue from physician learners themselves.1 CME is increasingly underwritten by commercial sponsors – primarily manufacturers of drugs, biologic therapies, or medical devices – that spend more than $1 billion per year in educational grants and other funding to cover more than half the costs for CME activities.1 Industry funding . . .